Cargando…
Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma
Background: We evaluated the prognostic value of Sarcopenia, low precardial adipose-tissue (PAT), and high tumor-volume in the outcome of surgically-treated pleural mesothelioma (PM). Methods: From 2005 to 2020, consecutive surgically-treated PM-patients having a pre-operative computed tomography (C...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774409/ https://www.ncbi.nlm.nih.gov/pubmed/35054268 http://dx.doi.org/10.3390/diagnostics12010099 |
_version_ | 1784636335175237632 |
---|---|
author | Verhoek, Oliver Guido Jungblut, Lisa Lauk, Olivia Blüthgen, Christian Opitz, Isabelle Frauenfelder, Thomas Martini, Katharina |
author_facet | Verhoek, Oliver Guido Jungblut, Lisa Lauk, Olivia Blüthgen, Christian Opitz, Isabelle Frauenfelder, Thomas Martini, Katharina |
author_sort | Verhoek, Oliver Guido |
collection | PubMed |
description | Background: We evaluated the prognostic value of Sarcopenia, low precardial adipose-tissue (PAT), and high tumor-volume in the outcome of surgically-treated pleural mesothelioma (PM). Methods: From 2005 to 2020, consecutive surgically-treated PM-patients having a pre-operative computed tomography (CT) scan were retrospectively included. Sarcopenia was assessed by CT-based parameters measured at the level of the fifth thoracic vertebra (TH5) by excluding fatty-infiltration based on CT-attenuation. The findings were stratified for gender, and a threshold of the 33rd percentile was set to define sarcopenia. Additionally, tumor volume as well as PAT were measured. The findings were correlated with progression-free survival and long-term mortality. Results: Two-hundred-seventy-eight PM-patients (252 male; 70.2 ± 9 years) were included. The mean progression-free survival was 18.6 ± 12.2 months, and the mean survival time was 23.3 ± 24 months. Progression was associated with chronic obstructive pulmonary disease (COPD) (p = <0.001), tumor-stage (p = 0.001), and type of surgery (p = 0.026). Three-year mortality was associated with higher patient age (p = 0.005), presence of COPD (p < 0.001), higher tumor-stage (p = 0.015), and higher tumor-volume (p < 0.001). Kaplan-Meier statistics showed that sarcopenic patients have a higher three-year mortality (p = 0.002). While there was a negative correlation of progression-free survival and mortality with tumor volume (r = 0.281, p = 0.001 and r = −0.240, p < 0.001; respectively), a correlation with PAT could only be shown for epithelioid PM (p = 0.040). Conclusions: Sarcopenia as well as tumor volume are associated with long-term mortality in surgically treated PM-patients. Further, while there was a negative correlation of progression-free survival and mortality with tumor volume, a correlation with PAT could only be shown for epithelioid PM. |
format | Online Article Text |
id | pubmed-8774409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87744092022-01-21 Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma Verhoek, Oliver Guido Jungblut, Lisa Lauk, Olivia Blüthgen, Christian Opitz, Isabelle Frauenfelder, Thomas Martini, Katharina Diagnostics (Basel) Article Background: We evaluated the prognostic value of Sarcopenia, low precardial adipose-tissue (PAT), and high tumor-volume in the outcome of surgically-treated pleural mesothelioma (PM). Methods: From 2005 to 2020, consecutive surgically-treated PM-patients having a pre-operative computed tomography (CT) scan were retrospectively included. Sarcopenia was assessed by CT-based parameters measured at the level of the fifth thoracic vertebra (TH5) by excluding fatty-infiltration based on CT-attenuation. The findings were stratified for gender, and a threshold of the 33rd percentile was set to define sarcopenia. Additionally, tumor volume as well as PAT were measured. The findings were correlated with progression-free survival and long-term mortality. Results: Two-hundred-seventy-eight PM-patients (252 male; 70.2 ± 9 years) were included. The mean progression-free survival was 18.6 ± 12.2 months, and the mean survival time was 23.3 ± 24 months. Progression was associated with chronic obstructive pulmonary disease (COPD) (p = <0.001), tumor-stage (p = 0.001), and type of surgery (p = 0.026). Three-year mortality was associated with higher patient age (p = 0.005), presence of COPD (p < 0.001), higher tumor-stage (p = 0.015), and higher tumor-volume (p < 0.001). Kaplan-Meier statistics showed that sarcopenic patients have a higher three-year mortality (p = 0.002). While there was a negative correlation of progression-free survival and mortality with tumor volume (r = 0.281, p = 0.001 and r = −0.240, p < 0.001; respectively), a correlation with PAT could only be shown for epithelioid PM (p = 0.040). Conclusions: Sarcopenia as well as tumor volume are associated with long-term mortality in surgically treated PM-patients. Further, while there was a negative correlation of progression-free survival and mortality with tumor volume, a correlation with PAT could only be shown for epithelioid PM. MDPI 2022-01-03 /pmc/articles/PMC8774409/ /pubmed/35054268 http://dx.doi.org/10.3390/diagnostics12010099 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Verhoek, Oliver Guido Jungblut, Lisa Lauk, Olivia Blüthgen, Christian Opitz, Isabelle Frauenfelder, Thomas Martini, Katharina Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title | Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title_full | Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title_fullStr | Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title_full_unstemmed | Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title_short | Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma |
title_sort | sarcopenia, precardial adipose tissue and high tumor volume as outcome predictors in surgically treated pleural mesothelioma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774409/ https://www.ncbi.nlm.nih.gov/pubmed/35054268 http://dx.doi.org/10.3390/diagnostics12010099 |
work_keys_str_mv | AT verhoekoliverguido sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT jungblutlisa sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT laukolivia sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT bluthgenchristian sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT opitzisabelle sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT frauenfelderthomas sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma AT martinikatharina sarcopeniaprecardialadiposetissueandhightumorvolumeasoutcomepredictorsinsurgicallytreatedpleuralmesothelioma |